StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GAD.TA$1350.00+2.58%
Fair $1350.00+0.0%

GAD.TA

Gad-Dairies (Marketing 1992) Ltd.

Consumer Defensive / Packaged FoodsTel Aviv

$1350.00

+35.00 (+2.58%)

Fairly Valued+0.0%Fair Value $1350.00Fund rank 38/100 · Data gapFallback financials|
SA 48/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $42.3M · quality 81.3/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 81/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · GAD.TALocal privado en este navegador · Gad-Dairies (Marketing 1992) Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.3B

P/E

22.5x

↑

EV/EBITDA

1502.0x

↑

ROE

16.0%

↑

Gross Margin

28.0%

↑

Debt/Equity

0.09

↓
52-Week Range$1350
$10$1598

TradingView lightweight chart

GAD.TA price, volumen y niveles de valoración

Último $1,390Periodo +12135.9%
Fair value: $1,350

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.7%

FCF CAGR

-7.8%

FCF margin

3.6%

FCF / Net income

0.57x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $720.8M · net income $45.9M · FCF $26.1M

2022-FY → 2025-FY

Gross margin

28.0%+1.0% pts

Operating margin

8.8%+3.6% pts

Net margin

6.4%+1.4% pts

FCF margin

3.6%-2.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$720.8M$720.8M$676.2M$611.5M$577.5M
Net Income$45.9M$45.9M$38.5M$24.5M$28.8M
EBITDA$87.0M$87.0M$78.8M$61.3M$55.9M
EPS——0.400.250.30
Gross Margin28.0%28.0%29.1%27.9%27.0%
Operating Margin8.8%8.8%9.4%8.1%5.2%
Net Margin6.4%6.4%5.7%4.0%5.0%
Balance Sheet
Debt/Equity0.090.091.101.22—
Current Ratio1.061.06———
Cash Flow
Free Cash Flow$26.1M$26.1M$47.9M$42.3M$33.3M
Returns
ROE16.0%16.0%44.6%29.5%—
Valuation
P/E22.5022.50———
EV/EBITDA1501.971501.97———
P/B454.84454.84———
Growth & Yield
Revenue Growth6.6%6.6%10.6%5.9%—
EPS Growth——56.9%-14.9%—
Dividend Yield1.1%1.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total +12137.0%

Total return

+12137.0%

Start / end P/E

n/dx → n/dx

EPS bridge

0.40 → n/d

Residual

+12135.9%

EPS growthn/d
Multiple reratingn/d
Dividend+1.1%
Residual / FX / buybacks / cross-term+12135.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.